Cleared Traditional

K061066 - SYNERGY HIP SYSTEM

K061066 is the FDA 510(k) clearance for SYNERGY HIP SYSTEM by Smith & Nephew, Inc.. It is a Class 2 General & Plastic Surgery device (product code LZO) cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K061066 · Smith & Nephew, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2006
Decision
88d
Days
Class 2
Risk

K061066 is an FDA 510(k) clearance for the SYNERGY HIP SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Smith & Nephew, Inc. (Memphis, US). The FDA issued a Cleared decision on July 14, 2006 after a review of 88 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 888.3353 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Smith & Nephew, Inc. devices

Submission Details

510(k) Number K061066 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 2006
Decision Date July 14, 2006
Days to Decision 88 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d faster than avg
Panel avg: 115d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 432
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K061066.
MODIFICATION: TO DEPUY DELTA CERAMIC FEMORAL HEAD
K062748 · DePuy Orthopaedics, Inc. · Nov 2006
NOVATION SPLINED RDD FEMORAL STEMS
K063279 · Exactech, Inc. · Nov 2006
EXCIA TOTAL HIP SYSTEM 36MM CERAMIC HEAD
K062684 · Aesculap, Inc. · Nov 2006
PATIENT MATCHED HIP STEM
K053246 · Smith & Nephew, Inc. · Jul 2006
36MM BIOLOX DELTA CERAMIC HEADS
K061312 · Biomet, Inc. · Jun 2006
EXCIA TOTAL HIP SYSTEM 12/14 TRUNNION WITH CERAMIC HEAD
K060918 · Aesculap, Inc. · May 2006